AEA. S. Ermolayeva

A. S. Ermolayeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. S. Ermolayeva has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mycoplasma pneumonia: Modern antibacterial therapy

    by N. B. Lazareva, S. S. Solovieva, A. S. Ermolaeva, M. E. Andreeva

    Mycoplasma pneumoniae (M. pneumoniae) is one of the key pathogens causing the community-acquired pneumonia in all countries, especially in children and adolescents. Globally, M. pneumoniae infections occur in different regions of the world every 3–7 years and last 1–2 years. M. pneumoniae has infective factors characterized by high affinity to the epithelial cells of the respiratory tract, direct damaging effect, as well as ability to interact with immune system cells. The pathogenesis of mycoplasma infection, i.e. pneumonia, includes both direct damage and immune response mediated by vasculitis and thrombosis. Macrolides are used as the main class of antibiotics for the treatment of mycoplasma infection. They inhibit bacterial growth by binding to 23S rRNA and inhibiting protein synthesis. However, macrolide-resistant strains of M. pneumoniae (MRMP) have become widespread in Asia since 2000, accounting for about 80–90% infections in China and Japan today, at the same time, the detection rate of MRMP is very low in European countries and the US. Azithromycin and clarithromycin have high bioavailability, are stable at acidic pH, oral forms do not require intestinal coating. Instant soluble drug forms (azithromycin) and suspension can be used by patients regardless of food intake, which ensures convenience. While the slow released drug forms of azithromycin should be taken only on an empty stomach, the slow released extended forms of clarithromycin should be taken with food.

  • Clinical and diagnostic significance of somatic diseases skin manifestations

    by A.A. Gazdanova, S.A. Knyazeva, A.S. Ermolaeva, E.D. Drejcer, V.A. Volodina, H.A. Bunina, A.P. Ivanova, E.E. Madonova, M.A. Stepanova

    The review describes skin changes in diseases of the cardiovascular and respiratory systems, liver, pancreas, endocrine system, kidneys, inflammatory diseases of the intestine, and hematological and rheumatic diseases. Some skin manifestations, such as annular erythema and rheumatic nodules in rheumatism, Lukin and Janeway spots, Osler nodules in infective endocarditis, are among the large (in rheumatism) and small (in infective endocarditis) criteria for establishing a diagnosis. Cutaneous vasculitis is an extra-articular manifestation of Sjogren’s disease, systemic lupus erythematosus, nodular polyarteritis, and other diffuse connective tissue diseases. Erythema nodosum is seen in sarcoidosis, tuberculosis, and many autoimmune disorders. Xanthomas and xanthelasmas may indicate a lipid metabolism disorder in atherosclerosis, metabolic syndrome, and biliary cirrhosis. Patients with various skin discoloration, hyperpigmentation, and depigmentation are not uncommon in clinical practice. The correct interpretation of the skin manifestations by the first contact physician will help to make the diagnostic route of the patient shorter and more adequate and ensure not symptomatic but etiopathogenetic treatment.


  • The effectiveness of BIFIFORM KIDS in the prevention of the incidence of acute respiratory infections in children

    by E.V. Shikh, V.N. Drozdov, O.A. Vorobieva, O.V. Zhukova, A.S. Ermolaeva, D.N. Tsvetkov, A.A. Bagdasaryan

    Возможности применения пробиотика БИФИФОРМ КИДС с целью профилактики заболеваемости острыми респираторными вирусными инфекциями у детей


  • Open Access

    Modern and promising ways of bowel preparation for instrumental research

    by E. V. Kanner, M. L. Maximov, A. S. Ermolaeva, I. D. Kanner, N. M. Lapkin

    A review is presented to summarize data on intestinal preparation approaches and methods for research. The historical background and main stages in the development of the intestinal lavage method are highlighted, and traditional and modern methods of evaluating its effectiveness are characterized. Dietary recommendations and information about the basic drugs used nowadays in preparation of the intestine for instrumental research are adduced. Clinical aspects of different types of osmotic action of drugs are considered. The composition of laxatives for salt and electrolyte components in terms of potential benefit and risk in patients is analyzed. The main positions of the current recommendations of domestic, European and American expert communities concerning the discussed topic are taken into account. Demonstrated “no less efficacy” of sulfate solution compared with macrogol in adult patients. Clinical case is presented: patient A., 22 years old, admitted to the clinic with complaints of recurrent pain in the left abdomen, frequent stools, sometimes with blood, loss of hair, flaky spots on the skin of the upper extremities. The patient was prepared for the examination – colon cleansing with a sulfate drug, endoscopic examination of the colon - colonoscopy was performed. Diagnosis: nonspecific ulcerative colitis. The treatment scheme is presented, clinical remission of the disease is achieved.


  • Open Access

    What methods are currently available to prevent and treat antibiotic-associated diarrhoea in children?

    by E. V. Kanner, A. V. Gorelov, M. L. Maksimov, A. S. Ermolayeva, I. S. Bulgakova

    Какие способы профилактики и лечения антибиотик-ассоциированной диареи у детей существуют в настоящее время?